Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUAL-PAD: Rivaroxaban plus Aspirin in PAD
NCT04218656Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in peripheral artery disease (PAD), sponsored by Radboud University Medical Center. Started Jun 2020; status: completed.
02
Drugs
rivaroxaban
03
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT04218656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04218656.